Medwing has secured €44 millions Series C funding
MEDWING has enjoyed continued success since its inception in 2017 with more than 500,000 candidates & 5,500 medical employers registered on its platform in the UK and Germany. The additional capital will help the company to continue its journey to becoming the leading healthcare job marketplace in Europe. VP Vianney Barre, has commented: “The healthcare system […]
Quadrille Capital appoints three new Partners
to strengthen its leadership position in financing growth companies in Europe and the United States Quadrille Capital, the independent investment manager in Venture Capital and Growth Equity appoints three new partners to strengthen its leadership position in financing growth companies in Europe and the United States Alejandra Duran Gil, Vianney Barre and Edouard Brunet join […]
Swedish fintech Anyfin lands €30 million to help Europeans take control of their financial wellbeing
Anyfin provides smart tools to refinance existing consumer loans with improved interest rates. The Anyfin platform can assess user applications in a few seconds and can help customers save around 50% on the cost of their loan. Over the course of 2022, the company experienced fivefold growth and the mobile app has now been downloaded […]
Homa raises another $100 million for its data-driven mobile gaming tools
Homa empowers game developers with data-fueled insights, analytics and testing capabilities to increase efficiency through every step of the game production and publishing cycles. Developers can therefore focus on creativity, while dramatically increasing their speed of execution and maximizing their chances of success. The new funding will enable Homa to further enhance its data-driven platform, […]
Quadrille Capital at a glance: a technology and healthcare focused platform
We invest globally across maturities in both Primary and Secondary private and public markets. A financially driven strategy offering 4 key investment solutions, a truly institutional firm with +40 professionals, +20 years of tech and healthcare VC and Growth Equity investment experience.
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
BigHat Biosciences is a biotech company founded in 2019 designing safer, more effective next-generation antibody therapies for patients with the combination of machine learning and synthetic biology. The company is led by a team of experts spanning machine learning, molecular biology, drug development, and medicine. Considering the complexity and cost of drug development, the (bio)pharmaceutical […]